Viewing Study NCT04806633


Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2025-12-26 @ 1:21 AM
Study NCT ID: NCT04806633
Status: UNKNOWN
Last Update Posted: 2021-03-19
First Post: 2021-03-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention
Sponsor: G.Gennimatas General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module